Daniela C Salles
Overview
Explore the profile of Daniela C Salles including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
23
Citations
296
Followers
0
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Association of Genomic Prostate Score at positive margin with recurrence after radical prostatectomy
Nourmohammadi Abadchi S, Salles D, Flannery C, Sama V, Baehner F, Zambon J, et al.
BJU Int
. 2024 Jul;
134(6):939-944.
PMID: 38953550
Objectives: To evaluate the utility of the 17-gene Genomic Prostate Score® (GPS; MDxHealth, Irvine, CA, USA) performed on prostate cancer at the positive margin of the radical prostatectomy (RP) for...
2.
Ding C, Su Z, Erak E, De Paula Oliveira L, Salles D, Jing Y, et al.
J Natl Cancer Inst
. 2024 Jun;
116(10):1683-1686.
PMID: 38889303
Deep learning (DL)-based algorithms to determine prostate cancer (PCa) Grade Group (GG) on biopsy slides have not been validated by comparison to clinical outcomes. We used a DL-based algorithm, AIRAProstate,...
3.
Omar M, Xu Z, Rand S, Alexanderani M, Salles D, Valencia I, et al.
Mol Cancer Res
. 2024 Jan;
22(4):347-359.
PMID: 38284821
Our study illuminates the potential of deep learning in effectively inferring key prostate cancer genetic alterations from the tissue morphology depicted in routinely available histology slides, offering a cost-effective method...
4.
Lozano R, Castro E, Lopez-Campos F, Thorne H, Ramirez-Backhaus M, Aragon I, et al.
Eur J Cancer
. 2023 Mar;
185:105-118.
PMID: 36972661
Background: Several studies have reported the association of germline BRCA2 (gBRCA2) mutations with poor clinical outcomes in prostate cancer (PCa), but the impact of concurrent somatic events on gBRCA2 carriers...
5.
Salles D, Mendes A, Han M, Partin A, Trock B, Jing Y, et al.
Mod Pathol
. 2023 Feb;
36(7):100147.
PMID: 36828362
Positive surgical margins at radical prostatectomy are associated with an increased risk of biochemical recurrence (BCR). However, there is considerable variability in outcomes, suggesting that molecular biomarkers-when assessed specifically at...
6.
Asrani K, Woo J, Mendes A, Schaffer E, Vidotto T, Villanueva C, et al.
Nat Commun
. 2022 Nov;
13(1):6808.
PMID: 36357396
The mechanistic target of rapamycin complex 1 (mTORC1) integrates inputs from growth factors and nutrients, but how mTORC1 autoregulates its activity remains unclear. The MiT/TFE transcription factors are phosphorylated and...
7.
Bakbak H, Sayar E, Kaur H, Salles D, Patel R, Hicks J, et al.
Hum Pathol
. 2022 Oct;
130:18-24.
PMID: 36309296
Genomic studies have demonstrated a high level of intra-tumoral heterogeneity in prostate cancer. There is strong evidence suggesting that individual tumor foci can arise as genetically distinct, clonally independent lesions....
8.
Salles D, Asrani K, Woo J, Vidotto T, Liu H, Vidal I, et al.
J Pathol
. 2022 Jan;
257(2):158-171.
PMID: 35072947
GPNMB (glycoprotein nonmetastatic B) and other TFE3/TFEB transcriptional targets have been proposed as markers for microphthalmia (MiT) translocation renal cell carcinomas (tRCCs). We recently demonstrated that constitutive mTORC1 activation via...
9.
Kaur H, Vidotto T, Mendes A, Salles D, Isaacs W, Antonarakis E, et al.
Cancer Immunol Immunother
. 2021 Sep;
71(4):943-951.
PMID: 34533610
Pathogenic mutations in homologous recombination (HR) DNA repair genes may be associated with increased tumor mutational burden and numbers of tumor-infiltrating lymphocytes (TIL). Though HR-deficient prostate tumors have been anecdotally...
10.
Sena L, Salles D, Engle E, Zhu Q, Tukachinsky H, Lotan T, et al.
Cold Spring Harb Mol Case Stud
. 2021 Jun;
7(4).
PMID: 34140335
Parenchymal brain metastases from prostate cancer are unusual and are associated with poor prognosis. Given the rarity of this entity, little is known about its molecular and histologic characteristics. Here...